(Q37924059)

25 August 2017

1 reference

title

Budesonide for the treatment of autoimmune hepatitis (English)

1 reference

25 August 2017

Kenneth R Snider

1

1 reference

25 August 2017

Teresa G Potter

series ordinal

2

1 reference

25 August 2017

language of work or name

English

0 references

publication date

30 August 2011

1 reference

Annals of Pharmacotherapy

25 August 2017

published in

1 reference

25 August 2017

volume

45

1 reference

25 August 2017

issue

9

1 reference

25 August 2017

page(s)

1144-1150

1 reference

25 August 2017

1 reference

Diagnosis and management of autoimmune hepatitis

21 January 2018

1 reference

Cyclosporin in the treatment of corticosteroid resistant autoimmune chronic active hepatitis

21 January 2018

1 reference

Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitis.

21 January 2018

1 reference

Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis

21 January 2018

1 reference

Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy.

21 January 2018

1 reference

A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis

21 January 2018

1 reference

Mycophenolate mofetil as second line therapy in autoimmune hepatitis?

21 January 2018

1 reference

Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease

21 January 2018

1 reference

Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.

21 January 2018

1 reference

Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy

21 January 2018

1 reference

Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus

21 January 2018

1 reference

Use of mycophenolate in the treatment of autoimmune hepatitis

21 January 2018

1 reference

Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis

21 January 2018

1 reference

Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis

21 January 2018

1 reference

The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine

21 January 2018

1 reference

Budesonide in previously untreated autoimmune hepatitis.

21 January 2018

1 reference

Budesonide induces complete remission in autoimmune hepatitis

21 January 2018

1 reference

The use of budesonide in the treatment of autoimmune hepatitis in Canada

21 January 2018

1 reference

Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis

21 January 2018

1 reference

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1Q244

1 reference

25 August 2017

1 reference